2007
DOI: 10.1007/s11910-007-0031-5
|View full text |Cite
|
Sign up to set email alerts
|

Update on the management of familial central nervous system tumor syndromes

Abstract: Hereditary central nervous tumor syndromes are a varied group of conditions that include neurofibromatosis type 1 and 2, tuberous sclerosis, Von Hippel-Lindau disease, and Cowden, Turcot, and Gorlin syndromes. The responsible genes have been identified in most of these disorders. These genes typically act as tumor suppressor genes, maintain normal cellular function and homeostasis, and regulate cell growth and differentiation. Familial central nervous system tumors are mostly inherited as autosomal dominant tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(9 citation statements)
references
References 78 publications
0
9
0
Order By: Relevance
“…A distinctive osseous lesion, such as sphenoid wing dysplasia or thinning of long bone cortex with or without pseudoarthrosis A fi rst-degree relative with neurofi bromatosis type I according to the above criteria (From Hottinger and Khakoo [64], with permission.) proptosis, optic disc atrophy, and precocious puberty [ 26 , 28 ].…”
Section: Table 1 Clinical Diagnostic Criteria For Neurofi Bromatosismentioning
confidence: 99%
“…A distinctive osseous lesion, such as sphenoid wing dysplasia or thinning of long bone cortex with or without pseudoarthrosis A fi rst-degree relative with neurofi bromatosis type I according to the above criteria (From Hottinger and Khakoo [64], with permission.) proptosis, optic disc atrophy, and precocious puberty [ 26 , 28 ].…”
Section: Table 1 Clinical Diagnostic Criteria For Neurofi Bromatosismentioning
confidence: 99%
“…TSC most often results from spontaneous genetic mutations [3][4][5][6][7][8][9] in one or two genes, TSC1 and TSC2, which encode hamartin and tuberin, respectively. These gene products form a physical and functional complex that inhibits the mammalian target of rapamycin (mTOR) pathway [10][11][12] and results in disorganized cellular growth, abnormal differentiation, and, ultimately, tumor growth [13][14][15][16] .…”
Section: Introductionmentioning
confidence: 99%
“…3 Other rare CNS lesions associated with VHLD include cerebellar ependymomas, astrocytomas, neuroblastomas, dermoid cysts, arteriovenous malformations, and primitive neuroectodermal tumors. 6 Suprasellar and intrasellar hemangioblastomas have been documented. [9][10][11] There is one case report of pituitary adenoma and paraganglioma in a patient with VHLD.…”
Section: Discussionmentioning
confidence: 99%